The device was received, the investigation could not be completed, and no conclusion could be drawn, as product is entering the complaint system.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.H3, h4, h6: part: 03.404.020s, lot: 51p3938: release to warehouse date: march 30, 2020.Expiration date: february 28, 2030.Supplier: jabil-monument.No no-conformance reports (ncrs) were generated during production.Review of the device history record showed that there were no issues during the manufacture of this product, and any subcomponents, which would contribute to this complaint condition.H3, h6: a product investigation was completed: the reamer heads proximal prongs were completely broken off, they were not returned.There was a red substance that was located on the reaming head.The substance was probably blood residue that was not removed during sterilization.Since no x-rays were provided capturing the embedded prongs, the reported condition of an embedded device was not confirmed however the overall complaint was confirmed due to the broken prongs.The dimensional inspection was not performed due to post manufacturing damage.The current and manufactured to drawings were reviewed.The overall complaint was confirmed.Although no definitive root-cause can be determined the reamer head may have been subjected to unexpected forces.There was no indication that a design or manufacturing issue contributed to the complaint.No design issues were observed during the document / specification review.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post market safety surveillance activities.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|